Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01607905
Title Safety Study of the Selective Inhibitor of Nuclear Export (SINE) KPT-330 in Patients With Advanced or Metastatic Solid Tumor Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Karyopharm Therapeutics, Inc
Indications

colorectal cancer

lung non-small cell carcinoma

peritoneal carcinoma

ovarian carcinoma

head and neck squamous cell carcinoma

fallopian tube carcinoma

prostate cancer

Advanced Solid Tumor

cervix carcinoma

malignant astrocytoma

glioblastoma

Therapies

Selinexor

Age Groups: adult
Covered Countries USA | CAN


No variant requirements are available.